Hemostemix (CVE:HEM) Share Price Passes Below Fifty Day Moving Average – Should You Sell?

by · The Markets Daily

Hemostemix Inc. (CVE:HEM – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.08 and traded as low as C$0.07. Hemostemix shares last traded at C$0.07, with a volume of 8,000 shares traded.

Hemostemix Stock Down 12.5 %

The stock has a market capitalization of C$6.10 million, a P/E ratio of -3.50 and a beta of 0.20. The firm has a 50-day moving average of C$0.08 and a 200 day moving average of C$0.07.

Hemostemix Company Profile

(Get Free Report)

Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia.

Further Reading